By admin, 24 September, 2026 Neuland to open $20m* dedicated Process Development facility with integrated kilo labs in Hyderabad
By admin, 15 September, 2026 Neuland Accelerates Peptide Manufacturing Expansion with First Commercial Module Operational
By Anonymous (not verified), 3 September, 2026 Pharmaceutical API Stability: Protecting API Quality from Development to Commercial Supply
By Anonymous (not verified), 3 September, 2026 The Complete Drug Development Pipeline: From Discovery to Commercial Scale
By Anonymous (not verified), 3 September, 2026 Biotech CDMOs and the Shift Toward Outsourced Drug Development
By admin, 31 August, 2026 Neuland Laboratories Expands Sterile API Manufacturing Capacity Through Strategic Collaboration with Gland Pharma
By Anonymous (not verified), 26 August, 2026 Why Peptide Capacity Cannot Be Measured by Equipment Size Alone
By Anonymous (not verified), 19 August, 2026 Ensuring Batch-to-Batch Consistency in Commercial API Production